Details
Stereochemistry | RACEMIC |
Molecular Formula | C13H19N3OS |
Molecular Weight | 265.374 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCOC(C1=CC=CS1)C2=CC=NN2C
InChI
InChIKey=CIJATQMMNKXTJJ-UHFFFAOYSA-N
InChI=1S/C13H19N3OS/c1-15(2)8-9-17-13(12-5-4-10-18-12)11-6-7-14-16(11)3/h4-7,10,13H,8-9H2,1-3H3
Molecular Formula | C13H19N3OS |
Molecular Weight | 265.374 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11509213
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11509213
Dilopetine is a racemic mixture of (+)-E-6006 citrate (E-6101) and (-)-E6006 citrate (E-6102) enantiomers being developed as a potential antidepressant. Initial experiments indicate that dilopetine exhibits an antidepressant profile in tests with mice and rats. Dilopetine has been observed to normalize the increased substance P levels in the periaqueductal gray of rats during stressor exposure (Hamon, personal communication), suggesting that the drug may function by inhibiting substance P release. Treatment with dilopetine reduced the vocalizing of isolated guinea pig pups in a dose-dependent fashion.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effects of a novel potential antidepressant on the behavior and cortisol levels of isolated guinea pig pups. | 2001 Jul-Aug |
|
Validation of a chromatographic method to determine E-6006 and its metabolite E-6332 in rat and dog plasma by solid-phase extraction and capillary gas chromatography. Application in pharmacokinetics. | 2001 Mar |
|
Enantioseparation of basic pharmaceutical compounds by capillary electrophoresis using sulfated cyclodextrins. Application to E-6006, a novel antidepressant. | 2003 Mar 21 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11509213
Single dose - 30 or 100 mg/kg body weight
Route of Administration:
Intraperitoneal
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:15:28 GMT 2023
by
admin
on
Fri Dec 15 17:15:28 GMT 2023
|
Record UNII |
5PSG6X4RGG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Fri Dec 15 17:15:28 GMT 2023 , Edited by admin on Fri Dec 15 17:15:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID20947645
Created by
admin on Fri Dec 15 17:15:28 GMT 2023 , Edited by admin on Fri Dec 15 17:15:28 GMT 2023
|
PRIMARY | |||
|
9816767
Created by
admin on Fri Dec 15 17:15:28 GMT 2023 , Edited by admin on Fri Dec 15 17:15:28 GMT 2023
|
PRIMARY | |||
|
8615
Created by
admin on Fri Dec 15 17:15:28 GMT 2023 , Edited by admin on Fri Dec 15 17:15:28 GMT 2023
|
PRIMARY | |||
|
300000034260
Created by
admin on Fri Dec 15 17:15:28 GMT 2023 , Edited by admin on Fri Dec 15 17:15:28 GMT 2023
|
PRIMARY | |||
|
C81479
Created by
admin on Fri Dec 15 17:15:28 GMT 2023 , Edited by admin on Fri Dec 15 17:15:28 GMT 2023
|
PRIMARY | |||
|
5PSG6X4RGG
Created by
admin on Fri Dec 15 17:15:28 GMT 2023 , Edited by admin on Fri Dec 15 17:15:28 GMT 2023
|
PRIMARY | |||
|
247046-52-2
Created by
admin on Fri Dec 15 17:15:28 GMT 2023 , Edited by admin on Fri Dec 15 17:15:28 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |